Drugs / BDHK-2009
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07632573 | May → Dec 2026 expected | Crohn disease, ulcerative colitis | Benethera (Shaoxing) Biotechnology Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BDHK-2009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07632573 ↗ |
| Route | Oral | “Administration: Oral” NCT07632573 ↗ |